BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28364817)

  • 1. Management of Immunosuppression in Liver Transplantation.
    Dhanasekaran R
    Clin Liver Dis; 2017 May; 21(2):337-353. PubMed ID: 28364817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression in liver transplantation.
    Mukherjee S; Botha JF; Mukherjee U
    Curr Drug Targets; 2009 Jun; 10(6):557-74. PubMed ID: 19519358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ABCs of Immunosuppression: A Primer for Primary Care Physicians.
    Malat G; Culkin C
    Med Clin North Am; 2016 May; 100(3):505-18. PubMed ID: 27095642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression in pediatric liver transplant recipients: Unique aspects.
    Miloh T; Barton A; Wheeler J; Pham Y; Hewitt W; Keegan T; Sanchez C; Bulut P; Goss J
    Liver Transpl; 2017 Feb; 23(2):244-256. PubMed ID: 27874250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Use of Immunosuppression in Liver Transplantation.
    Adjei M; Kim IK
    Surg Clin North Am; 2024 Feb; 104(1):11-25. PubMed ID: 37953030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive Therapy in Transplantation.
    Allison TL
    Nurs Clin North Am; 2016 Mar; 51(1):107-20. PubMed ID: 26897428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppression for lung transplantation.
    Bhorade SM; Stern E
    Proc Am Thorac Soc; 2009 Jan; 6(1):47-53. PubMed ID: 19131530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients.
    Charlton M; Levitsky J; Aqel B; OʼGrady J; Hemibach J; Rinella M; Fung J; Ghabril M; Thomason R; Burra P; Little EC; Berenguer M; Shaked A; Trotter J; Roberts J; Rodriguez-Davalos M; Rela M; Pomfret E; Heyrend C; Gallegos-Orozco J; Saliba F
    Transplantation; 2018 May; 102(5):727-743. PubMed ID: 29485508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic Monitoring to Personalize Immunosuppression After Liver Transplant.
    Zhu A; Leto A; Shaked A; Keating B
    Gastroenterol Clin North Am; 2018 Jun; 47(2):281-296. PubMed ID: 29735024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Implications of the immunologic response to the graft in the design of immunosuppressive treatment for liver transplantation].
    de la Mata M; Barrera P; Montero JL; Fraga E; Briceño J; Pozo JC; Solórzano G
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():52-6. PubMed ID: 15195535
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
    Charlton M; Seaberg E
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S107-14. PubMed ID: 10431024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcineurin inhibitors in liver transplantation: to be or not to be.
    Castroagudín JF; Molina E; Varo E
    Transplant Proc; 2011; 43(6):2220-3. PubMed ID: 21839238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of immunosuppression in recurrence of hepatitis C.
    Lake JR
    Liver Transpl; 2003 Nov; 9(11):S63-6. PubMed ID: 14586898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Future prospects in immunosuppression for liver transplantation.
    Fung JJ; Bollinger JE; Miller C; Eghtesad B
    Liver Transpl; 2011 Nov; 17 Suppl 3():S54-9. PubMed ID: 21850695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Status of liver and gastrointestinal transplantation at the University of Miami.
    Weppler D; Khan R; Fragulidis GP; Nery JR; Ricordi C; Tzakis AG
    Clin Transpl; 1996; ():187-201. PubMed ID: 9286568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal dose and type of immunosuppression in a national cohort of Australian liver, heart, and lung transplant recipients, 1984-2006.
    Na R; Laaksonen MA; Grulich AE; Webster AC; Meagher NS; McCaughan GW; Keogh AM; Vajdic CM
    Clin Transplant; 2015 Nov; 29(11):978-90. PubMed ID: 26278925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimization of immunosuppression: transplant immunology.
    Patel J; Kobashigawa JA
    Transpl Immunol; 2008 Nov; 20(1-2):48-54. PubMed ID: 18930138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends of Immunosuppression and Outcomes Following Liver Transplantation: An Analysis of the United Network for Organ Sharing Registry.
    Cheng EY; Everly MJ
    Clin Transpl; 2014; ():13-26. PubMed ID: 26281123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcineurin inhibitor-free immunosuppression in kidney transplantation.
    Guerra G; Srinivas TR; Meier-Kriesche HU
    Transpl Int; 2007 Oct; 20(10):813-27. PubMed ID: 17645419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppression in organ transplantation.
    Jordan SC; Rosenthal P; Makowka L
    Semin Pediatr Surg; 1993 Nov; 2(4):206-7. PubMed ID: 8062042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.